Here are two stocks that could deliver monster returns over the next five years. Upstart ( UPST 5.22%) burned plenty of ...

Asian equities were mixed overnight in a quiet session following Friday’s global index rebalance and the expiration of US ...

Of late, pharmaceutical behemoth Pfizer Inc.’s PFE stock has struggled, but it remains a bargain with generous dividends. Its ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

China is making efforts to highlight the country’s business opportunities to major American corporations like Apple (AAPL), ...

Oracle has delivered impressive gains in the past five years. Oracle sees faster growth over the next few years thanks to its ...

We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look ...

Pfizer's attractive dividend yield and low P/E ratio make it appealing. Learn why PFE stock's valuation risks may be higher ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

How GLP-1 drugs, regulatory concerns, and more factors are shaping the sector. Plus, 3 undervalued healthcare stocks.

If you're looking for reasonably priced stocks to pick up right now, you shouldn't overlook Pfizer (NYSE: PFE). The ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...